KLSE Traders Update and Ideas

Daily Market Update - 11 Dec 2015

mplus313
Publish date: Fri, 11 Dec 2015, 11:08 AM
mplus313
0 3,761
This blog provides market updates and trading ideas that I gather from around the web.

M+ Online Morning Buzz - 11 Dec 15: Dow +82.45 pts (+0.47%) @ 17,574.75 pts. The U.S. stockmarkets rebounded overnight led by gains in healthcare and energy stocks. In contrast, utilities and materials sectors were amongst the biggest losers on the S&P 500 sectors. Separately, the new applications for unemployment benefits rose higher-than-expected (13,000) to 282,000 in the week ended on 5th December 2015.

Following the losses in most index-linked heavyweights, the FBM KLCI continued to register losses for its third straight session. The MACD Histogram has extended another red bar, while the RSI has hovers above the 30 level. The immediate resistance will be envisaged around the 1,700 level. Support is pegged around the 1,600-1,630 levels.

Sector Focus: Technology

Technology: N2N, EFFICEN, MPAY

Others: EG, TEKSENG, APB, HALEX, TEXCHEM, JAYCORP

Potential Momentum Stocks: 

N2N (0108): Monitor for follow-through buying interest above the RM1.00 psychological level. TP: RM1.05-RM1.10 SL: RM0.94.

EFFICEN (0064): Price formed a flag formation breakout above the RM0.31 level. TP: RM0.33-RM0.35. SL: RM0.305.

APB (5568): Price surged above the EMA 9 level with improvement in volumes. TP: RM1.57. SL: RM1.40.

Source: M+ Online

 

Disclaimer

The content published is solely for information and personal use only. It should not be construed to be, any advice, recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. Readers should seek independent advice from their own professional advisers (including legal, tax, financial and accounting) as to the risks and merits before entering into any transaction pursuant to or in reliance on any information here.

The content published above shall only be for your sole and personal non-professional use. No guarantee is given on the accuracy or completeness of the information published here. No warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person or group of persons acting on such information.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment